Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 816 results for "merck co"

Merck board OKs additional $10 billion stock buyback plan
Boston Globe

Merck in $10B Buyback; Keytruda Tops Melanoma Study

Merck & Co. Inc. ( MRK - Analyst Report ) announced that its board has approved a share buyback program wherein the company will purchase up to $10 billion worth of shares. Following the announcement, Merck's repurchase authorization stands at ..., 22 hours ago
Merck To Buyback $10 Bln Stock, 2 days ago

53 images for merck co

Jutia Group, 1 week ago, 1 day ago, 2 weeks ago
Value Walk, 2 weeks ago, 2 days ago
Columbus Republic, 2 weeks ago
I Stock Analyst, 1 day ago
North, 1 month ago
FOX 5 KVVU-TV, 2 weeks ago
BioSpace, 6 days ago

Merck's phase 3 KEYNOTE-006 study of Keytruda to treat advanced melanoma meets co-primary endpoints

Merck, known as MSD outside the United States and Canada, announced that the randomized, pivotal phase 3 study (KEYNOTE-006) investigating Keytruda (pembrolizumab) compared to ipilimumab in the first-line treatment of patients with advanced melanoma ...
 PharmaBiz1 day ago Merck & Co. Announces New $10 Billion Share Repurchase Program  BioSpace1 day ago Merck (MRK) Stock Gains Today on Positive Phase III Melanoma Treatment Study Results  TheStreet.com2 days ago Merck's Pivotal KEYNOTE-006 Study in First-Line Treatment for Advanced Melanoma Met Co-Primary Endpoints and Will be Stopped Early  Yahoo! UK and Ireland2 days ago

Merck (MRK) Showing Resistance Near $60.14

MarketIntelligenceCenter.comaEUR(TM)s patented algorithms have chosen the Jun. '15 $57.50 call for a couple of hedged-trading ideas on Merck & Co Inc. ("MRK). A traditional covered call on Merck ...
 Individual.com1 day ago Merck (MRK) Showing Support Near $57.30  Individual.com3 days ago

Merck's Dividend Has Recovered From Pre-Recession Problems

Mar. 25, 2015 8:48 AM ET | About: Merck & Co Inc. (MRK) by: . Summary Merck found itself in a precarious position in 2007 when it was making $1.49 in profits and paying out $1.52 in dividends. Because Merck chose not to cut its dividend, it ...
 Seeking Alpha1 day ago

Potential Merck (MRK) Trade Has 4.65% Downside Protection

Merck & Co Inc. ("MRK) presents a trading opportunity that offers a 2.68% return in just 87 days. A covered call on Merck at the $57.50 level expiring on Jun. '15 offers an assigned return rate of ...
 Individual.com2 days ago Potential Merck (MRK) Trade Has 3.49% Downside Protection  Individual.com6 days ago Potential Merck (MRK) Trade Has 3.09% Downside Protection  Individual.com1 week ago

Dow Movers: IBM, MRK

In early trading on Tuesday, shares of Merck & Co. (MRK) topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.0%. Year to date, Merck & Co. registers a 4.4% gain. And the worst performing Dow ...
 Forbes.com2 days ago Msft, mrk  4 Traders1 day ago Ibm, mrk  4 Traders2 days ago

Stocks Off To A Twitchy Start; Netflix, Twitter, Merck Surge

I nvestors, please fasten safety belts. Stocks opened lower, turned mixed, then rose early Tuesday as international and U.S. economic news flashed mixed signals. The Nasdaq was the first to reverse and was ahead 0.2%. The Dow and the S&P 500 clung ...
 Investor's Business Daily2 days ago U.S. Stocks Fall  Investors Hub1 day ago Stocks Fall on Uncertainty Over Slide in Durable Goods  TheStreet.com1 day ago Stock Futures Are Mixed; Kraft Surges on Heinz Merger News  TheStreet.com1 day ago

Study of Merck melanoma drug halted after survival prolonged

(Reuters) - Merck & Co Inc said on Tuesday a large study of its Keytruda melanoma treatment will be stopped early because an independent monitoring committee determined the drug succeeded in its goal of prolonging survival in previously untreated ...
 Reuters2 days ago Merck halts Keytruda study on positive results in melanoma  Pharma Letter2 days ago

NO ACT - Merck & Co., Inc. (0000310158) (Filer)

Document Format Files Seq Description Document Type Size 1 AUTO-GENERATED PAPER DOCUMENT 9999999997-15-005628.paper NO ACT 293 Complete submission text file
 SEC1 week ago

Merck Sells $4 Billion in Bonds to Back Sigma-Aldrich Purchase

(Bloomberg) -- Merck KGaA sold $4 billion of bonds in its biggest debt sale to help finance its $17 billion purchase of Sigma-Aldrich Corp. The German pharmaceutical and chemicals company issued the dollar-denominated securities in five parts that ...
 La Repubblica1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less